Medical drugs from humus matter: Focus on mumie

Authors: Schepetkin I (1) , Khlebnikov A (2) , Kwon BS (1)
Affiliations:
(1) Immunomodulation Research Center and Department of Biology Science, University of Ulsan (2) Altai State Technical University
Source: Drug Development Research Volume 57, Issue 3, pages 140–159, November 2002
DOI: 10.1002/ddr.10058 Publication date: 2002 Nov E-Publication date: Dec. 19, 2002 Availability: abstract Copyright: © 2002 Wiley-Liss, Inc.
Language: English Countries: Not specified Location: Not specified Correspondence address: Byoung Se Kwon,
Immunomodulation Research Center, University of Ulsan, P.O. Box 18, Moo-Keo Dong, Nam-Ku, Ulsan, 680-749, Korea
Email : bskwon@uou.ulsan.ac.kr

Keywords

Article abstract

In this review, we focus on the medicinal drugs from humus matter such as peat, sapropel, and mumie. The most clinically available medicines, containing peat and sapropel extracts, are Torfot, Tolpa Peat Preparation (TPP), Peloidodistillate, Humisol, Peloidin, FiBS, and Eplir. Much attention in the review is concentrated on mumie composition, its pharmacological properties, and new pharmacological drugs with mumie (Shilagen, Abana, Cystone, Diabecon 400, EveCare, Geriforte, Lukol, Pilex, Rumalava, Tentex forte, Nefrotec, Adrenotone, Siotone, La-Tone Gold, Andro-Surge, Solanova Libidoplex). It was concluded that therapeutic properties of crude extracts from peat, sapropel, and mumie have similarity to the ones of fulvic and humic acids. They are antibacterial, antitoxic, antiradical, antiulcerogenic, antiarthritic, immunomodulatory, and antiinflammatory properties. Possible directions for better development of new drugs from humus matter are discussed.

Find it online

Haut de page